Skip to main content


The foundation of innovation is rapidly changing in the life science sector and new technologies bring new challenges and opportunities for funding and support of early stage growth. This panel session will look at different models for supporting the translation/commercialization of early stage research and technology which are shaping the life science sector today.  

Programme:
18:00 Registration over tea and coffee

18:30 Welcome from the hosts

18:40 Panel Q&A: The Evolution of Funding and Support for Early Stage Research
          Chair: Fiona Nicolson, Partner, Bristows LLP
          Panellists:
          Dr Ian McKay, Innovation Lead for Advanced Therapies, Innovate UK
          Donna Hackett, Head of Commercial Translation, The Francis Crick Institute
          Dr Derek Sheader, Business Development Manager, LifeArc
          Dr Daniel Marshall, Senior Associate, Epidarex Capital

19.30 Networking over drinks and canapes

21:00 Close

Prices
Members: Free
Non-members: £50 +VAT
Academics: please contact alicia@onenucleus.com


**This button will not work if you are not logged in**

 

Contact

BioWednesday London: The Evolution of Funding and Support for Early Stage Research

18:00 - 21:00 Wednesday 25th September 2019
25 September 2019 18:00
Bristows LLP
100 Victoria Embankment
London EC4Y 0DH
United Kingdom
Member Pricesfrom
Non-Member Pricefrom